Regenerative Medicine

Home About us

Regenerative Medicine is an interface between a traditional device and human tissue, working to augment dysfunctional tissues or organs. This line of research strives to improve a function within body or cells by combining both device and cell research.

Regenerative Medicine focuses on the core of the CII, working to improve heart and vasculature systems. The team is currently using the technology of electrospinning to create tissue scaffolds for blood vessel and heart repair. Polymers are used to make extra fine fibers, or bio-mimicking materials, which the human body does not detect as foreign, letting the body heal more naturally.  The fibers eventually resorb, leaving nothing but true human tissue in place where the initial injury once lived.

Tissue dissociation and adipose tissue are also being researched as additional cell sources, using these technologies to make off-the-shelf tissue engineered fiber which can be put into the patient at the time of the surgical intervention.

Division Leader and Principal Investigator

Eugene Boland, Ph.D.

Research Programs

  • Tissue Engineered Vascular Grafts
  • Heart Patches
  • Congenital Heart Defect Repair
  • Closure devices for fistulas

 

Technologies

  • Electrospinning
  • Adult Stem Cells
  • Autologous primary cells
  • Soft Tissue Mechanical Characterization
  • Histological evaluation of tissues


For more information concerning Regenerative Medicine.

Document Actions
Personal tools